These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 32016963)

  • 1. Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis.
    Hao SD; Ma JX; Liu Y; Liu PJ; Qin Y
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):619-632. PubMed ID: 32016963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro.
    Tang Y; Yang P; Zhu Y; Su Y
    Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 4. Long noncoding RNA TUG1 regulates the progression of colorectal cancer through miR-542-3p/TRIB2 axis and Wnt/β-catenin pathway.
    Liu Q; Zhang W; Luo L; Han K; Liu R; Wei S; Guo X
    Diagn Pathol; 2021 May; 16(1):47. PubMed ID: 34030715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
    Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of TUG1/miRNA-299-3p Axis Represses Pancreatic Cancer Malignant Progression via Suppression of the Notch1 Pathway.
    Xu K; Zhang L
    Dig Dis Sci; 2020 Jun; 65(6):1748-1760. PubMed ID: 31655908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
    Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
    Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
    Xie C; Chen B; Wu B; Guo J; Cao Y
    Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo.
    Li Y; Zheng D; Pan L; Dai Y; Cai S; Zhao L; Zhu H
    Eur J Pharmacol; 2019 Oct; 860():172536. PubMed ID: 31310753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p/HDAC3 axis.
    Su Q; Liu Y; Lv XW; Dai RX; Yang XH; Kong BH
    Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H332-H344. PubMed ID: 31858814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0081143 Contributes to Gastric Cancer Malignant Development and Doxorubicin Resistance by Elevating the Expression of YES1 by Targeting mziR-129-2-3p.
    Ou W; Lin L; Chen R; Xu Q; Zhou C
    Gut Liver; 2022 Nov; 16(6):861-874. PubMed ID: 35686503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-140 inhibit prostate cancer cell invasion and migration by targeting YES proto-oncogene 1.
    Zhao S; Jie C; Xu P; Diao Y
    J Cell Biochem; 2020 Jan; 121(1):482-488. PubMed ID: 31310382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of the lncRNA
    Zhang B; Zhao C; Hou L; Wu Y
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1125-F1134. PubMed ID: 33135476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNHG16 Silencing Inhibits Neuroblastoma Progression by Downregulating HOXA7 via Sponging miR-128-3p.
    Bao J; Zhang S; Meng Q; Qin T
    Neurochem Res; 2020 Apr; 45(4):825-836. PubMed ID: 31919621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.
    Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J
    Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of long noncoding RNA TUG1 inhibits viability and promotes apoptosis of acute myeloid leukemia cells by targeting microRNA-221-3p/KIT axis.
    Zhang X; Yang L; Xu G
    Clin Hemorheol Microcirc; 2020; 76(3):425-437. PubMed ID: 32804119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNA TUG1 Promotes the Function in ox-LDL-Treated HA-VSMCs via miR-141-3p/ROR2 Axis.
    Tang Y; Hu J; Zhong Z; Liu Y; Wang Y
    Cardiovasc Ther; 2020; 2020():6758934. PubMed ID: 32565910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of lncRNA TUG1 upregulates miR-142-3p to ameliorate myocardial injury during ischemia and reperfusion via targeting HMGB1- and Rac1-induced autophagy.
    Su Q; Liu Y; Lv XW; Ye ZL; Sun YH; Kong BH; Qin ZB
    J Mol Cell Cardiol; 2019 Aug; 133():12-25. PubMed ID: 31145943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.